Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1994 Nov;57(11):1303–1307. doi: 10.1136/jnnp.57.11.1303

Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

H J Willison
PMCID: PMC1073177  PMID: 7964802

Full text

PDF
1303

Images in this article

1304Image
on p.1304

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai M., Yoshino H., Kusano Y., Yazaki Y., Ohnishi Y., Miyatake T. Ataxic polyneuropathy and anti-Pr2 IgM kappa M proteinemia. J Neurol. 1992 Mar;239(3):147–151. doi: 10.1007/BF00833915. [DOI] [PubMed] [Google Scholar]
  2. Arasaki K., Kusunoki S., Kudo N., Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve. 1993 Jun;16(6):587–593. doi: 10.1002/mus.880160603. [DOI] [PubMed] [Google Scholar]
  3. Ariga T., Kohriyama T., Freddo L., Latov N., Saito M., Kon K., Ando S., Suzuki M., Hemling M. E., Rinehart K. L., Jr Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy. J Biol Chem. 1987 Jan 15;262(2):848–853. [PubMed] [Google Scholar]
  4. Bollensen E., Steck A. J., Schachner M. Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy. Neurology. 1988 Aug;38(8):1266–1270. doi: 10.1212/wnl.38.8.1266. [DOI] [PubMed] [Google Scholar]
  5. Braun P. E., Frail D. E., Latov N. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem. 1982 Nov;39(5):1261–1265. doi: 10.1111/j.1471-4159.1982.tb12563.x. [DOI] [PubMed] [Google Scholar]
  6. Chaudhry V., Corse A. M., Cornblath D. R., Kuncl R. W., Drachman D. B., Freimer M. L., Miller R. G., Griffin J. W. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol. 1993 Mar;33(3):237–242. doi: 10.1002/ana.410330303. [DOI] [PubMed] [Google Scholar]
  7. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 1993 Oct;43(10):1911–1917. doi: 10.1212/wnl.43.10.1911. [DOI] [PubMed] [Google Scholar]
  8. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992 Jun;31(6):677–679. doi: 10.1002/ana.410310619. [DOI] [PubMed] [Google Scholar]
  9. Chou D. K., Ilyas A. A., Evans J. E., Costello C., Quarles R. H., Jungalwala F. B. Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J Biol Chem. 1986 Sep 5;261(25):11717–11725. [PubMed] [Google Scholar]
  10. Daune G. C., Farrer R. G., Dalakas M. C., Quarles R. H. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside. Ann Neurol. 1992 Jun;31(6):683–685. doi: 10.1002/ana.410310621. [DOI] [PubMed] [Google Scholar]
  11. Enders U., Karch H., Toyka K. V., Michels M., Zielasek J., Pette M., Heesemann J., Hartung H. P. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol. 1993 Aug;34(2):136–144. doi: 10.1002/ana.410340208. [DOI] [PubMed] [Google Scholar]
  12. Endo T., Scott D. D., Stewart S. S., Kundu S. K., Marcus D. M. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol. 1984 Apr;132(4):1793–1797. [PubMed] [Google Scholar]
  13. Feldman E. L., Bromberg M. B., Albers J. W., Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol. 1991 Sep;30(3):397–401. doi: 10.1002/ana.410300312. [DOI] [PubMed] [Google Scholar]
  14. Freddo L., Yu R. K., Latov N., Donofrio P. D., Hays A. P., Greenberg H. S., Albers J. W., Allessi A. G., Keren D. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology. 1986 Apr;36(4):454–458. doi: 10.1212/wnl.36.4.454. [DOI] [PubMed] [Google Scholar]
  15. Gregory R., Thomas P. K., King R. H., Hallam P. L., Malcolm S., Hughes R. A., Harding A. E. Coexistence of hereditary motor and sensory neuropathy type Ia and IgM paraproteinemic neuropathy. Ann Neurol. 1993 Jun;33(6):649–652. doi: 10.1002/ana.410330615. [DOI] [PubMed] [Google Scholar]
  16. Gregson N. A., Jones D., Thomas P. K., Willison H. J. Acute motor neuropathy with antibodies to GM1 ganglioside. J Neurol. 1991 Dec;238(8):447–451. doi: 10.1007/BF00314652. [DOI] [PubMed] [Google Scholar]
  17. Gregson N. A., Koblar S., Hughes R. A. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med. 1993 Feb;86(2):111–117. [PubMed] [Google Scholar]
  18. Griffin J. W., Ho T. W. The Guillain-Barré syndrome at 75: the Campylobacter connection. Ann Neurol. 1993 Aug;34(2):125–127. doi: 10.1002/ana.410340204. [DOI] [PubMed] [Google Scholar]
  19. Hays A. P., Latov N., Takatsu M., Sherman W. H. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology. 1987 Feb;37(2):242–256. doi: 10.1212/wnl.37.2.242. [DOI] [PubMed] [Google Scholar]
  20. Heidenreich F., Leifeld L., Jovin T. T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro. J Neuroimmunol. 1994 Jan;49(1-2):97–108. doi: 10.1016/0165-5728(94)90185-6. [DOI] [PubMed] [Google Scholar]
  21. Heiman-Patterson T., Krupa T., Thompson P., Nobile-Orazio E., Tahmoush A. J., Shy M. E. Anti-GM1/GD1b M-proteins damage human spinal cord neurons co-cultured with muscle. J Neurol Sci. 1993 Dec 1;120(1):38–45. doi: 10.1016/0022-510x(93)90022-q. [DOI] [PubMed] [Google Scholar]
  22. Herron B., Willison H. J., Veitch J., Roelcke D., Illis L. S., Boulton F. E. Monoclonal IgM cold agglutinins with anti-Pr1d specificity in a patient with peripheral neuropathy. Vox Sang. 1994;67(1):58–63. doi: 10.1111/j.1423-0410.1994.tb05039.x. [DOI] [PubMed] [Google Scholar]
  23. Ilyas A. A., Cook S. D., Dalakas M. C., Mithen F. A. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide. J Neuroimmunol. 1992 Mar;37(1-2):85–92. doi: 10.1016/0165-5728(92)90158-h. [DOI] [PubMed] [Google Scholar]
  24. Ilyas A. A., Mithen F. A., Chen Z. W., Cook S. D. Anti-GM1 IgA antibodies in Guillain-Barré syndrome. J Neuroimmunol. 1992 Jan;36(1):69–76. doi: 10.1016/0165-5728(92)90031-f. [DOI] [PubMed] [Google Scholar]
  25. Ilyas A. A., Mithen F. A., Chen Z. W., Cook S. D. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome. J Neurol Sci. 1991 Mar;102(1):67–75. doi: 10.1016/0022-510x(91)90095-o. [DOI] [PubMed] [Google Scholar]
  26. Ilyas A. A., Mithen F. A., Dalakas M. C., Chen Z. W., Cook S. D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 1992 Jan;107(1):111–121. doi: 10.1016/0022-510x(92)90217-9. [DOI] [PubMed] [Google Scholar]
  27. Ilyas A. A., Mithen F. A., Dalakas M. C., Wargo M., Chen Z. W., Bielory L., Cook S. D. Antibodies to sulfated glycolipids in Guillain-Barré syndrome. J Neurol Sci. 1991 Sep;105(1):108–117. doi: 10.1016/0022-510x(91)90126-r. [DOI] [PubMed] [Google Scholar]
  28. Ilyas A. A., Quarles R. H., Dalakas M. C., Fishman P. H., Brady R. O. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann Neurol. 1985 Dec;18(6):655–659. doi: 10.1002/ana.410180605. [DOI] [PubMed] [Google Scholar]
  29. Ilyas A. A., Quarles R. H., MacIntosh T. D., Dobersen M. J., Trapp B. D., Dalakas M. C., Brady R. O. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc Natl Acad Sci U S A. 1984 Feb;81(4):1225–1229. doi: 10.1073/pnas.81.4.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ilyas A. A., Willison H. J., Quarles R. H., Jungalwala F. B., Cornblath D. R., Trapp B. D., Griffin D. E., Griffin J. W., McKhann G. M. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol. 1988 May;23(5):440–447. doi: 10.1002/ana.410230503. [DOI] [PubMed] [Google Scholar]
  31. Kaldor J., Speed B. R. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1867–1870. doi: 10.1136/bmj.288.6434.1867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kornberg A. J., Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve. 1994 Jan;17(1):100–104. doi: 10.1002/mus.880170115. [DOI] [PubMed] [Google Scholar]
  33. Lamb N. L., Patten B. M. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies. Muscle Nerve. 1991 Oct;14(10):1021–1027. doi: 10.1002/mus.880141014. [DOI] [PubMed] [Google Scholar]
  34. Lange D. J., Trojaborg W. Do GM1 antibodies induce demyelination? Muscle Nerve. 1994 Jan;17(1):105–107. doi: 10.1002/mus.880170116. [DOI] [PubMed] [Google Scholar]
  35. Latov N., Hays A. P., Donofrio P. D., Liao J., Ito H., McGinnis S., Konstadoulakis M., Freddo L., Shy M. E., Manoussos K. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology. 1988 May;38(5):763–768. doi: 10.1212/wnl.38.5.763. [DOI] [PubMed] [Google Scholar]
  36. Lee K. W., Inghirami G., Spatz L., Knowles D. M., Latov N. The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation. J Neuroimmunol. 1991 Jan;31(1):83–88. doi: 10.1016/0165-5728(91)90090-t. [DOI] [PubMed] [Google Scholar]
  37. Lewis R. A., Sumner A. J., Brown M. J., Asbury A. K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982 Sep;32(9):958–964. doi: 10.1212/wnl.32.9.958. [DOI] [PubMed] [Google Scholar]
  38. Li Y. T., Månsson J. E., Vanier M. T., Svennerholm L. Structure of the major glucosamine-containing ganglioside of human tissues. J Biol Chem. 1973 Apr 10;248(7):2634–2636. [PubMed] [Google Scholar]
  39. Marcus D. M., Latov N., Hsi B. P., Gillard B. K. Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A. J Neuroimmunol. 1989 Dec;25(2-3):255–259. doi: 10.1016/0165-5728(89)90144-6. [DOI] [PubMed] [Google Scholar]
  40. Merrill A. H., Jr, Hannun Y. A., Bell R. M. Introduction: sphingolipids and their metabolites in cell regulation. Adv Lipid Res. 1993;25:1–24. [PubMed] [Google Scholar]
  41. Nardelli E., Steck A. J., Barkas T., Schluep M., Jerusalem F. Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b. Ann Neurol. 1988 May;23(5):524–528. doi: 10.1002/ana.410230517. [DOI] [PubMed] [Google Scholar]
  42. Nobile-Orazio E., Carpo M., Legname G., Meucci N., Sonnino S., Scarlato G. Anti-GM1 IgM antibodies in motor neuron disease and neuropathy. Neurology. 1990 Nov;40(11):1747–1750. doi: 10.1212/wnl.40.11.1747. [DOI] [PubMed] [Google Scholar]
  43. Nobile-Orazio E., Carpo M., Meucci N., Grassi M. P., Capitani E., Sciacco M., Mangoni A., Scarlato G. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci. 1992 Jun;109(2):200–206. doi: 10.1016/0022-510x(92)90169-l. [DOI] [PubMed] [Google Scholar]
  44. Nobile-Orazio E., Carpo M., Meucci N., Grassi M. P., Capitani E., Sciacco M., Mangoni A., Scarlato G. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci. 1992 Jun;109(2):200–206. doi: 10.1016/0022-510x(92)90169-l. [DOI] [PubMed] [Google Scholar]
  45. Obi T., Kusunoki S., Takatsu M., Mizoguchi K., Nishimura Y. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides. Acta Neurol Scand. 1992 Aug;86(2):215–218. doi: 10.1111/j.1600-0404.1992.tb05069.x. [DOI] [PubMed] [Google Scholar]
  46. Ohsawa T., Miyatake T., Yuki N. Anti-B-series ganglioside-recognizing autoantibodies in an acute sensory neuropathy patient cause cell death of rat dorsal root ganglion neurons. Neurosci Lett. 1993 Jul 23;157(2):167–170. doi: 10.1016/0304-3940(93)90728-4. [DOI] [PubMed] [Google Scholar]
  47. Parry G. J. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve. 1994 Jan;17(1):97–99. doi: 10.1002/mus.880170114. [DOI] [PubMed] [Google Scholar]
  48. Parry G. J., Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve. 1988 Feb;11(2):103–107. doi: 10.1002/mus.880110203. [DOI] [PubMed] [Google Scholar]
  49. Pestronk A., Adams R. N., Clawson L., Cornblath D., Kuncl R. W., Griffin D., Drachman D. B. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 1988 Sep;38(9):1457–1461. doi: 10.1212/wnl.38.9.1457. [DOI] [PubMed] [Google Scholar]
  50. Pestronk A., Adams R. N., Cornblath D., Kuncl R. W., Drachman D. B., Clawson L. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Ann Neurol. 1989 Jan;25(1):98–102. doi: 10.1002/ana.410250118. [DOI] [PubMed] [Google Scholar]
  51. Pestronk A., Chaudhry V., Feldman E. L., Griffin J. W., Cornblath D. R., Denys E. H., Glasberg M., Kuncl R. W., Olney R. K., Yee W. C. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol. 1990 Mar;27(3):316–326. doi: 10.1002/ana.410270314. [DOI] [PubMed] [Google Scholar]
  52. Pestronk A., Cornblath D. R., Ilyas A. A., Baba H., Quarles R. H., Griffin J. W., Alderson K., Adams R. N. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol. 1988 Jul;24(1):73–78. doi: 10.1002/ana.410240113. [DOI] [PubMed] [Google Scholar]
  53. Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve. 1991 Oct;14(10):927–936. doi: 10.1002/mus.880141002. [DOI] [PubMed] [Google Scholar]
  54. Pestronk A., Li F., Griffin J., Feldman E. L., Cornblath D., Trotter J., Zhu S., Yee W. C., Phillips D., Peeples D. M. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology. 1991 Mar;41(3):357–362. doi: 10.1212/wnl.41.3.357. [DOI] [PubMed] [Google Scholar]
  55. Quarles R. H., Ilyas A. A., Willison H. J. Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system. Chem Phys Lipids. 1986 Dec 15;42(1-3):235–248. doi: 10.1016/0009-3084(86)90055-1. [DOI] [PubMed] [Google Scholar]
  56. Roberts M., Willison H., Vincent A., Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet. 1994 Feb 19;343(8895):454–455. doi: 10.1016/s0140-6736(94)92694-8. [DOI] [PubMed] [Google Scholar]
  57. SVENNERHOLM L. CHROMATOGRAPHIC SEPARATION OF HUMAN BRAIN GANGLIOSIDES. J Neurochem. 1963 Sep;10:613–623. doi: 10.1111/j.1471-4159.1963.tb08933.x. [DOI] [PubMed] [Google Scholar]
  58. Sadiq S. A., Thomas F. P., Kilidireas K., Protopsaltis S., Hays A. P., Lee K. W., Romas S. N., Kumar N., van den Berg L., Santoro M. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology. 1990 Jul;40(7):1067–1072. doi: 10.1212/wnl.40.7.1067. [DOI] [PubMed] [Google Scholar]
  59. Salazar-Grueso E. F., Routbort M. J., Martin J., Dawson G., Roos R. P. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants. Ann Neurol. 1990 May;27(5):558–563. doi: 10.1002/ana.410270517. [DOI] [PubMed] [Google Scholar]
  60. Santoro M., Uncini A., Corbo M., Staugaitis S. M., Thomas F. P., Hays A. P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol. 1992 Apr;31(4):385–390. doi: 10.1002/ana.410310407. [DOI] [PubMed] [Google Scholar]
  61. Schwartz M., Sela B. A., Eshhar N. Antibodies to gangliosides and myelin autoantigens are produced in mice following sciatic nerve injury. J Neurochem. 1982 May;38(5):1192–1195. doi: 10.1111/j.1471-4159.1982.tb07890.x. [DOI] [PubMed] [Google Scholar]
  62. Schwerer B., Lassmann H., Kitz K., Bernheimer H. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol. 1986;72(1):55–61. doi: 10.1007/BF00687947. [DOI] [PubMed] [Google Scholar]
  63. Shy M. E., Evans V. A., Lublin F. D., Knobler R. L., Heiman-Patterson T., Tahmoush A. J., Parry G., Schick P., DeRyk T. G. Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia. Ann Neurol. 1989 May;25(5):511–513. doi: 10.1002/ana.410250517. [DOI] [PubMed] [Google Scholar]
  64. Simone I. L., Annunziata P., Maimone D., Liguori M., Leante R., Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 1993 Jan;114(1):49–55. doi: 10.1016/0022-510x(93)90048-4. [DOI] [PubMed] [Google Scholar]
  65. Smith I. S., Kahn S. N., Lacey B. W., King R. H., Eames R. A., Whybrew D. J., Thomas P. K. Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. Brain. 1983 Mar;106(Pt 1):169–195. doi: 10.1093/brain/106.1.169. [DOI] [PubMed] [Google Scholar]
  66. Steck A. J., Murray N., Meier C., Page N., Perruisseau G. Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology. 1983 Jan;33(1):19–23. doi: 10.1212/wnl.33.1.19. [DOI] [PubMed] [Google Scholar]
  67. Steck A. J., Murray N. Monoclonal antibodies to myelin-associated glycoprotein reveal antigenic structures and suggest pathogenic mechanisms. Springer Semin Immunopathol. 1985;8(1-2):29–43. doi: 10.1007/BF00197245. [DOI] [PubMed] [Google Scholar]
  68. Stefansson K., Marton L., Antel J. P., Wollmann R. L., Roos R. P., Chejfec G., Arnason B. G. Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol. 1983;59(4):255–261. doi: 10.1007/BF00691490. [DOI] [PubMed] [Google Scholar]
  69. Svennerholm L., Fredman P. Antibody detection in Guillain-Barré syndrome. Ann Neurol. 1990;27 (Suppl):S36–S40. doi: 10.1002/ana.410270710. [DOI] [PubMed] [Google Scholar]
  70. Tatum A. H. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol. 1993 May;33(5):502–506. doi: 10.1002/ana.410330514. [DOI] [PubMed] [Google Scholar]
  71. Tettamanti G., Riboni L. Gangliosides and modulation of the function of neural cells. Adv Lipid Res. 1993;25:235–267. [PubMed] [Google Scholar]
  72. Van den Bergh P., Logigian E. L., Kelly J. J., Jr Motor neuropathy with multifocal conduction blocks. Muscle Nerve. 1989 Jan;12(1):26–31. doi: 10.1002/mus.880120106. [DOI] [PubMed] [Google Scholar]
  73. Vriesendorp F. J., Mishu B., Blaser M. J., Koski C. L. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol. 1993 Aug;34(2):130–135. doi: 10.1002/ana.410340206. [DOI] [PubMed] [Google Scholar]
  74. Walsh F. S., Cronin M., Koblar S., Doherty P., Winer J., Leon A., Hughes R. A. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol. 1991 Oct;34(1):43–51. doi: 10.1016/0165-5728(91)90097-q. [DOI] [PubMed] [Google Scholar]
  75. Willison H. J., Chancellor A. M., Paterson G., Veitch J., Singh S., Whitelaw J., Kennedy P. G., Warlow C. P. Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study. J Neurol Sci. 1993 Feb;114(2):209–215. doi: 10.1016/0022-510x(93)90300-n. [DOI] [PubMed] [Google Scholar]
  76. Willison H. J., Kennedy P. G. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J Neuroimmunol. 1993 Jul;46(1-2):105–112. doi: 10.1016/0165-5728(93)90239-u. [DOI] [PubMed] [Google Scholar]
  77. Willison H. J., Paterson G., Kennedy P. G., Veitch J. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol. 1994 Apr;35(4):471–478. doi: 10.1002/ana.410350416. [DOI] [PubMed] [Google Scholar]
  78. Willison H. J., Paterson G., Veitch J., Inglis G., Barnett S. C. Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1178–1183. doi: 10.1136/jnnp.56.11.1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Willison H. J., Trapp B. D., Bacher J. D., Dalakas M. C., Griffin J. W., Quarles R. H. Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle Nerve. 1988 Nov;11(11):1169–1176. doi: 10.1002/mus.880111111. [DOI] [PubMed] [Google Scholar]
  80. Willison H. J., Veitch J., Paterson G., Kennedy P. G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204–206. doi: 10.1136/jnnp.56.2.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Winer J. B., Hughes R. A., Anderson M. J., Jones D. M., Kangro H., Watkins R. P. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry. 1988 May;51(5):613–618. doi: 10.1136/jnnp.51.5.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Yeung K. B., Thomas P. K., King R. H., Waddy H., Will R. G., Hughes R. A., Gregson N. A., Leibowitz S. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol. 1991 Oct;238(7):383–391. doi: 10.1007/BF00319857. [DOI] [PubMed] [Google Scholar]
  83. Yuki N., Sato S., Tsuji S., Hozumi I., Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci. 1993 Aug;118(1):83–87. doi: 10.1016/0022-510x(93)90250-3. [DOI] [PubMed] [Google Scholar]
  84. Yuki N., Sato S., Tsuji S., Ohsawa T., Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology. 1993 Feb;43(2):414–417. doi: 10.1212/wnl.43.2.414. [DOI] [PubMed] [Google Scholar]
  85. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993 Nov 1;178(5):1771–1775. doi: 10.1084/jem.178.5.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 1990 Dec;40(12):1900–1902. doi: 10.1212/wnl.40.12.1900. [DOI] [PubMed] [Google Scholar]
  87. Yuki N., Yoshino H., Sato S., Shinozawa K., Miyatake T. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve. 1992 Aug;15(8):899–903. doi: 10.1002/mus.880150806. [DOI] [PubMed] [Google Scholar]
  88. Zielasek J., Ritter G., Magi S., Hartung H. P., Toyka K. V. A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1. J Neurol. 1994 Jul;241(8):475–480. doi: 10.1007/BF00919708. [DOI] [PubMed] [Google Scholar]
  89. van den Berg L. H., Lankamp C. L., de Jager A. E., Notermans N. C., Sodaar P., Marrink J., de Jong H. J., Bär P. R., Wokke J. H. Anti-sulphatide antibodies in peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1164–1168. doi: 10.1136/jnnp.56.11.1164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. van den Berg L. H., Marrink J., de Jager A. E., de Jong H. J., van Imhoff G. W., Latov N., Sadiq S. A. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1992 Jan;55(1):8–11. doi: 10.1136/jnnp.55.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES